Lyell Immunopharma Inc (LYEL)

Nov 04, 2025

Lyell Immunopharma Appoints New Financial Leadership Team - MSN

Nov 04, 2025

Nov 04, 2025

Lyell’s dual-targeting CAR T-cell therapy shows promise in lymphoma - Investing.com Australia

Nov 04, 2025

Nov 04, 2025

How to manage a losing position in Lyell Immunopharma Inc.2025 Retail Activity & Stock Market Timing Techniques - newser.com

Nov 04, 2025

Nov 04, 2025

How institutional ownership impacts Lyell Immunopharma Inc. stockTrade Volume Report & Risk Controlled Stock Pick Alerts - newser.com

Nov 04, 2025

Nov 04, 2025

Strategies to average down on Lyell Immunopharma Inc.Weekly Loss Report & Consistent Return Investment Signals - newser.com

Nov 04, 2025

Nov 04, 2025

Published on: 2025-11-04 03:36:30 - newser.com

Nov 04, 2025

Nov 04, 2025

How Lyell Immunopharma Inc. stock performs in weak economyGap Up & Breakout Confirmation Trade Signals - newser.com

Nov 04, 2025

Nov 04, 2025

Will Lyell Immunopharma Inc. benefit from macro trendsWeekly Profit Analysis & High Return Stock Watch Alerts - newser.com

Nov 04, 2025

Nov 04, 2025

Is Lyell Immunopharma Inc. stock attractive for retirement portfoliosTrade Volume Summary & Detailed Earnings Play Strategies - newser.com

Nov 04, 2025

Nov 03, 2025

Is Lyell Immunopharma Inc. stock overvalued by current metricsTrade Analysis Report & Expert Verified Stock Movement Alerts - newser.com

Nov 03, 2025

Nov 03, 2025

Lyell (Nasdaq: LYEL) to present Phase 1/2 ronde-cel LBCL at ASH; FDA RMAT & Fast Track - Stock Titan

Nov 03, 2025

Nov 03, 2025

Lyell Immunopharma Announces Key Management Appointments - TradingView

Nov 03, 2025

Nov 03, 2025

[8-K] Lyell Immunopharma, Inc. Reports Material Event | LYEL SEC FilingForm 8-K - Stock Titan

Nov 03, 2025

Nov 03, 2025

Volatility clustering patterns for Lyell Immunopharma Inc.July 2025 Drop Watch & Stepwise Trade Execution Plans - newser.com

Nov 03, 2025

Nov 03, 2025

Real time social sentiment graph for Lyell Immunopharma Inc.2025 Momentum Check & Stock Portfolio Risk Management - newser.com

Nov 03, 2025

Nov 02, 2025

What hedge fund activity signals for Lyell Immunopharma Inc. stockProfit Target & Risk Controlled Swing Alerts - newser.com

Nov 02, 2025

Nov 02, 2025

Is this a good reentry point in Lyell Immunopharma Inc.Trade Risk Report & Low Drawdown Trading Techniques - newser.com

Nov 02, 2025

Nov 02, 2025

Tick level data insight on Lyell Immunopharma Inc. volatilityTrade Analysis Summary & Safe Capital Allocation Plans - newser.com

Nov 02, 2025

Nov 02, 2025

How to track smart money flows in Lyell Immunopharma Inc.July 2025 Update & Trade Opportunity Analysis - newser.com

Nov 02, 2025

Nov 01, 2025

Technical signs of recovery in Lyell Immunopharma Inc.2025 Buyback Activity & Weekly Chart Analysis and Guides - newser.com

Nov 01, 2025

Oct 31, 2025

Published on: 2025-10-31 03:26:35 - newser.com

Oct 31, 2025

Oct 31, 2025

Is it too late to sell Lyell Immunopharma Inc.Portfolio Gains Report & Weekly Stock Performance Updates - newser.com

Oct 31, 2025

Oct 31, 2025

Is Lyell Immunopharma Inc. still worth holding after the dipWeekly Profit Recap & Precise Swing Trade Entry Alerts - newser.com

Oct 31, 2025

Oct 30, 2025

Published on: 2025-10-30 06:17:45 - newser.com

Oct 30, 2025

Oct 30, 2025

Lyell Immunopharma (LYEL) to Release Quarterly Earnings on Thursday - MarketBeat

Oct 30, 2025

Oct 30, 2025

Published on: 2025-10-30 02:39:25 - newser.com

Oct 30, 2025

Oct 29, 2025

[Form 4] Lyell Immunopharma, Inc. Insider Trading Activity - Stock Titan

Oct 29, 2025